Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease
Stefan F. H. Neys, Jasper Rip, Rudi W. Hendriks, et al.
Drugs (2021) Vol. 81, Iss. 14, pp. 1605-1626
Open Access | Times Cited: 40

Showing 26-50 of 40 citing articles:

Scalable Synthesis of ABBV-105 Enabled by Suzuki Coupling with Low Pd Loading, Ru-Catalyzed Asymmetric Hydrogenation, and Acylation Using Impinging Jet
Benoit Cardinal‐David, Shashank Shekhar, Eric M. Phillips, et al.
Organic Process Research & Development (2024) Vol. 28, Iss. 8, pp. 3229-3247
Closed Access | Times Cited: 1
Zanubrutinib: a breakthrough in cancer therapy targeting Bruton’s tyrosine kinase, originating from China, and benefiting the global community
Sai‐Yang Zhang, Jian Song, Wenbo Liu, et al.
Elsevier eBooks (2024), pp. 431-442
Closed Access | Times Cited: 1
Ibrutinib protects against acute lung injury via inhibiting NLRP3/Caspase-1 in septic mice model
Huiming Tang, Hui Li, Yang Yang, et al.
Molecular Immunology (2022) Vol. 152, pp. 232-239
Closed Access | Times Cited: 7
Zanubrutinib Ameliorates Cardiac Fibrosis and Inflammation Induced by Chronic Sympathetic Activation
Wenqi Li, Shuwen Zhu, Jing Liu, et al.
(2023)
Open Access | Times Cited: 3
Structural Complementarity of Bruton’s Tyrosine Kinase and Its Inhibitors for Implication in B-Cell Malignancies and Autoimmune Diseases
Asim Najmi, Neelaveni Thangavel, Anugeetha Thacheril Mohanan, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 400-400
Open Access | Times Cited: 2
Decreased BAFF Receptor Expression and Unaltered B Cell Receptor Signaling in Circulating B Cells from Primary Sjögren’s Syndrome Patients at Diagnosis
Stefan F. H. Neys, Gwenny M. Verstappen, Hendrika Bootsma, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5101-5101
Open Access | Times Cited: 4
BTK Inhibitors in Haematology: Beyond B Cell Malignancies
Dr Emma Leitinger, Zane Kaplan
Transfusion Medicine Reviews (2022) Vol. 36, Iss. 4, pp. 239-245
Closed Access | Times Cited: 3
Bruton’s Kinase Inhibitors for the Treatment of Immunological Diseases: Current Status and Perspectives
Ewa Robak, Tadeusz Robak
Vide Leaf, Hyderabad eBooks (2022)
Open Access | Times Cited: 3
Therapeutic potential and recent progression of BTK inhibitors against rheumatoid arthritis
Swati Paliwal, Sandhya Bawa, Nishtha Shalmali, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 1
Closed Access
Tolerability, safety, and pharmacokinetics of GR1603 injection in healthy subjects: a randomized, double-blind, placebo-controlled single-dose escalation clinical trial
Xin Huang, Hong Xiang, Shuang Yang, et al.
Expert Opinion on Investigational Drugs (2024), pp. 1-7
Closed Access
Diagnosis and Molecular Pathology of Lymphoblastic Leukemias and Lymphomas in the Era of Genomics and Precision Medicine: Historical Evolution and Current Concepts—Part 3: Mature Leukemias/Lymphomas
Rina Kansal
Lymphatics (2023) Vol. 1, Iss. 2, pp. 155-219
Open Access | Times Cited: 1
A randomized, controlled single, and multiple ascending dose trial of the safety, pharmacokinetics and pharmacodynamics of SN1011 in healthy subjects
Leilei Zhu, Rong Shi, TongFang Zhao, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 10, pp. 1982-1996
Open Access | Times Cited: 1
Inborn errors of immunity and immunodeficiencies: Antibody‐mediated pathology and autoimmunity as a consequence of impaired immune reactions
Susana Minguet, Alexander Nyström, Dimitra Kiritsi, et al.
European Journal of Immunology (2022) Vol. 52, Iss. 9, pp. 1396-1405
Open Access | Times Cited: 1
Systematic simulation of the interactions of Pleckstrin homology domains with membranes
Kyle I. P. Le Huray, He Wang, Frank Sobott, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Et tu, Brutinib? Demise of a kinase target in rheumatoid arthritis?
Peter C. Taylor
The Lancet Rheumatology (2023) Vol. 5, Iss. 5, pp. e241-e243
Open Access
Previous Page - Page 2

Scroll to top